makinezmoney
2月前
$HBFFG: Seriously good FINANCIALS....... $20Milly Revs per quarter
I'm down for that for sure !!!!!!
GO $HBFGF
************************************************************************
Happy Belly Food Group Reports $19.3M in Q1 System Wide QSR Sales Up 80.4% Growth YOY
TMX Newsfile
May 13, 2026 4 min read
HBFG.CN
-1.42%
W3J.F
-2.31%
HBFGF
-2.88%
Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce its unaudited financial results and corporate update for the fiscal quarter ended March 31st, 2026.
Q1 2026 Financial and Recent Business Highlights
System-wide sales across Quick Service Restaurants (QSR") totalled $19.3M in the first quarter of fiscal 2026, up 80.4% versus the same quarter last year (2025 - $10.7M). The increase is attributed to organic baseline restaurant growth, alongside increased restaurant count, which reached 87 operating restaurants at the end of Q1 2026, up 74.0% versus 50 in the prior year.
Total operating revenues, services, interest income and rebates totalled $6.0M in the first quarter of fiscal 2026, up 82.2% versus the same quarter last year (2025 - $3.3M). Year-over-year growth was driven by continued sales growth in QSR, multiple business acquisitions in the past twelve months, and net new restaurants (10 new openings in Q1).
Total product sales totalled $4.7M in the first quarter of 2026, up 70.3% versus the same quarter last year (2025 - $2.8M). In addition, royalties and franchise fee revenues reached $0.97M during the quarter, up 118% from the prior year (2025 - $0.45M), which was driven by an increase in royalties collected from added franchised restaurants in the system.
Adjusted EBITDA was $(0.17M) or (2.9%) in the first quarter of fiscal 2026 versus $0.14M or 4.2% in the same quarter last year.
Total cash and cash equivalents remain healthy at $6.2M as of March 31, 2026 (2025 - $3.0M).
As of April 30, 2026, subsequent to fiscal 2025, the Company has opened and is operating 17 additional restaurants.
Management Commentary
"Happy Belly continued to deliver strong growth in the first quarter of fiscal 2026, with system-wide sales across our Quick Service Restaurant portfolio increasing 80.4% year over year to $19.3 million. This growth reflects continued organic baseline restaurant performance, the contribution of recent acquisitions, and the expansion of our operating restaurant base to 87 locations at quarter end, up 74.0% from the prior year," said Sean Black, Chief Executive Officer of Happy Belly Food Group. "During the quarter, we opened 10 new restaurants, further demonstrating the strength and repeatability of our growth model. Subsequent to quarter end, we continued that momentum, with 7 additional restaurants opened and operating. This continued expansion reinforces the demand for our brands and the effectiveness of our area developer and franchise platform."
"Total operating revenues also increased 82.2% year over year to $6.0 million, while total product sales increased 70.3% to $4.7 million. Importantly, royalties and franchise fee revenues grew 118% to $0.97 million, driven by the continued expansion of franchised restaurants across our system. This is a key metric for us as we scale towards 100+ operating locations in the first half of this year. As our restaurant footprint grows, these higher-margin revenue streams become an increasingly important contributor to our financial profile."
"With $6.2 million in cash at quarter end, and less than $60,000 in total secured debt, we remain well positioned to continue executing our strategy without having to slow down. We are proud of the progress made in Q1 2026 and remain focused on disciplined growth, operational execution, and scaling Happy Belly as a leading acquirer and operator of emerging food brands. Our expanding franchise system provides increased royalty and franchise fee revenues providing a strong foundation for long-term shareholder value creation. Moving forward in 2026 we anticipate delivering significant organic growth, surpassing our original expectations for the full year. With cash in the bank, building the business in the back half of 2026 is going to be a lot of fun".
"We are just getting started," said Sean Black.
Full details of the financial reports and operating results for the first quarter of fiscal 2026, are described in the Company's consolidated financial statements with accompanying notes and related Management's Discussion and Analysis, available on SEDAR+ at www.sedarplus.ca.
FOOTNOTES:
1. Adjusted EBITDA Is a non-IFRS financial measure which does not have a standardized meaning prescribed by IFRS. Adjusted EBITDA and Adjusted EBITDA Margin are used by management as supplemental measures to review and assess operating performance and to provide a more complete understanding of factors and trends impacting the Company's business. Management believes Adjusted EBITDA are useful measures of operating performance and the Company's ability to generate cash-based earnings, as they provide a more relevant position of operating results by excluding the effects of financing and investing activities, which removes the effects of interest, depreciation and amortization expenses as well as other expenses, as described, that are not reflective of the Company's underlying business. This non-IFRS measure is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.
Adjusted EBITDA is defined as net comprehensive income or (loss), excluding interest, taxes, depreciation and amortization (EBITDA), adjusted for share-based compensation, gain (loss) on equity investments and sublease, expected credit loss and non-recurring expenses.
Franchising
For franchising inquiries please see www.happybellyfg.com/franchise-with-us/ or contact us at hello@happybellyfg.com.
About Happy Belly Food Group
Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company") is a leader in acquiring and scaling emerging food brands across Canada.
Happy Belly 1
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6625/297276_93791fbc7493cbff_002full.jpg
Sean Black
Co-founder, Chief Executive Officer
Shawn Moniz
Co-founder, President
FOR FURTHER INFORMATION, PLEASE VISIT:
www: www.happybellyfg.com or email hello@happybellyfg.com
If you wish to contact us please call: 1-877-589-8805
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
PotterBanker
7年前
Cannvas Signs Exclusive Cannabis Education and Revenue Sharing Agreement With Luxury Automobile Club
https://www.newswire.ca/en/releases/archive/April2019/25/c5568.html
Quebec-Based Le Qlub First Member of Cannvas Drive Responsible Program
TORONTO, April 25, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has signed an agreement with Le Qlub, a premier Quebec-based exotic car rental company, to be its exclusive provider of cannabis education with the luxury automobile club as the first member of the Cannvas Drive Responsible Program. The agreement also supports revenue-sharing between the two organizations with Le Qlub offering exclusive discounts and promotions to Cannvas users.
"We are excited to partner with Le Qlub and welcome them to our Cannvas Drive Responsible Program, an ongoing awareness campaign we hope to expand across Canada with the support of strategic partners to promote education about the dangers of driving under the influence of cannabis," said Steve Loutsou, Chief Operating Officer, Cannvas MedTech. "Le Qlub and its clients win by learning more about cannabis, its potential benefits for a range of health concerns and the importance of safe and responsible driving for potential cannabis users, while Cannvas gains additional users educating themselves on all aspects of cannabis and sharing valuable research and consumption information - it's a win-win scenario for all parties."
Cannvas will provide printed educational material to be placed prominently in each vehicle in Le Qlub's fleet, including mirror hangers, window decals and glovebox flyers. Each piece will have information on safe cannabis consumption as it relates to driving, using material created for the Cannvas.Me digital cannabis education resource by the platform's independent Medical, Educational and Cannabis Sciences Advisory Boards.
The agreement also sets in place a lead-generating aspect wherein Le Qlub will offer exclusive discounts and promotions to Cannvas users, encouraging residents of and visitors to Quebec to complement their trip with the enjoyment of a reasonably-priced rental of a luxury automobile of their choice.
The agreement brings Le Qlub on board as the inaugural member of the Cannvas Drive Responsible Program, an initiative aimed at increasing awareness of the risks associated with driving under the influence of cannabis. According to a Statistics Canada report in the second quarter of 2018, "one in seven cannabis users reported driving at least once within two hours of using cannabis in the past three months, and one in 20 Canadians reported being a passenger in a vehicle driven by someone who had consumed cannabis in the previous two hours."
About Le Qlub
Le Qlub™ is a premier exotic car rental company for individuals in search of an exotic car rental in Montreal. Le Qlub™ provides a pristine luxury experience for new and experienced clientele. For more information please visit LeQlub.ca.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
PotterBanker
7年前
Cannvas Selected to Join The International Cannabis Alliance as Exclusive Provider of Cannabis Education
https://www.newswire.ca/news-releases/cannvas-selected-to-join-the-international-cannabis-alliance-as-exclusive-provider-of-cannabis-education-860650808.html
Industry Leaders Join Forces to Improve Accessibility to Unbiased and Evidence-Based Cannabis Education
TORONTO, April 24, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has joined the International Cannabis Alliance ("InterCannAlliance"), bringing advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe, as its exclusive provider of cannabis education. The InterCannAlliance is an international project led by New Frontier Data, an independent, technology-driven analytics company specializing in the cannabis industry.
"We are proud to join the International Cannabis Alliance in its efforts to educate future leaders in the global cannabis industry and develop a framework for delivering unbiased and evidence-based consumer education around cannabis as laid out in its nine founding pillars," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. "This opportunity extends the global reach of the Cannvas brand, opens doors to exciting new ventures and projects with partners spanning the globe, and strengthens our market position as a leader in cannabis education in Canada and across the world."
Cannvas will work with the InterCannAlliance to deliver physician-backed and evidence-based cannabis education powered by its digital cannabis learning resource Cannvas.Me. With a focus on audiences in new and evolving legal cannabis markets, InterCannAlliance will review all original content on Cannvas.Me and work with the Cannvas team to identify appropriate learning modules to adapt and make available to their community. The partnership also opens the door to opportunities for Cannvas to explore projects with New Frontier Data as part of its cannabis analytics platform Cannvas Data, as the two organizations share the same mission of elevating the discussion around the legal cannabis industry globally by providing unbiased vetted information and educating stakeholders to make informed decisions.
The International Cannabis Alliance was created in March of 2018 to bring advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe. Its mission is to educate and inform future market and thought leaders interested in the cannabis industry, fostering responsible, transparent and effective market practices learned across more mature North American cannabis sectors.
Uniting recognized leaders from industry segments considered to be critical building blocks for any cannabis market, InterCannAlliance seeks to simplify the complex and inconsistent regulatory environments being implemented across and within nations. The InterCannAlliance conducts one-day, invitation-only regional symposia to foster collaboration among governments, non-governmental organizations and commercial enterprises to educate stakeholders about opportunities, risks, and challenges in these markets.
About InterCannAlliance:
The International Cannabis Alliance (InterCannAlliance) was created in March of 2018 to bring advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe. As established and emerging markets look to cannabis to reinvigorate their economies, healthcare and a range of industries, InterCannAlliance unites recognized leaders from industry segments considered to be critical building blocks for any cannabis market. The organization seeks to simplify the complex and inconsistent regulatory environments being implemented across and within nations and to help emerging markets capitalize on lessons learned elsewhere. The InterCannAlliance conducts invitation-only quarterly regional symposia to facilitate collaboration among governments, non-government organizations and large commercial enterprises to expedite access to and assessment of opportunities while accelerating growth. For more information, visit www.intercannalliance.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: ir@cannvasmedtech.com or visit Cannvas.com
Related Links
https://cannvasmedtech.com
PotterBanker
7年前
Empower Announces Partnership With Cannvas MedTech to Advance Patient Education
https://www.newswire.ca/news-releases/empower-announces-partnership-with-cannvas-medtech-to-advance-patient-education-830832513.html
Empower Clinics Inc. is launching a pilot program with Cannvas MedTech to place educational kiosks in each of the Empower clinics to advance the education of patients, collection of data and analysis of physician recommended alternative CBD based therapies.
VANCOUVER, April 18, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented, diversified health and wellness company, is pleased to announce that it intends to partner with Cannvas MedTech Inc. ("Cannvas") (CSE: MTEC) (FRA: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, to create a pilot to launch a comprehensive education, data collection and analysis program starting with the installation of a network of standalone on-site Cannvas educational kiosks in the Empower network of medical clinics.
"This is an opportunity to bring unbiased cannabis education to a large population of patients looking for therapies to alleviate a number of ailments while also learning more about what behaviours may drive the decision to look at cannabis as an alternative or complementary treatment," said Shawn Moniz, Chief Executive Officer, Cannvas. "We are thrilled to partner with Empower Clinics to couple cannabis education with data analysis and better serve their patients while growing the Cannvas brand across the United States."
It is expected that Cannvas will place its Cannvas kiosks throughout Empower's network of clinics to provide accessible and unbiased cannabis education to Empower's patients, integrating geo-targeting capabilities to ensure relevant contextual information across the country. Cannvas will be a key data and analytics partner for Empower by providing meaningful insights on customer behaviours and industry trends and integrating mutually beneficial existing data partnerships.
"In recent weeks, the Company has been re-positioning its overall strategy to become a vertically integrated health and wellness company that connects to its 120,000 patients using a data driven focus to improve patients' lives with products, technology and health systems", stated Steven McAuley, Empower CEO, "the addition of the Cannvas educational kiosks, a user friendly and highly interactive education platform, is a tremendous step forward to making our brand one of the go to sources for content for both patients and the medical community nationwide."
Every month Empower hosts informational sessions about alternative treatment options and the potential health benefits with doctors and staff available to answer questions. It is expected that Cannvas will play an active role in the review and implementation of new educational curriculum based on original content from Cannvas website, Cannvas.me.
The Company also plans to begin further pilot initiatives with Cannvas to provide content and educational links to Cannvas.me and Cannvas.health directly from the new Empower website www.empowerclinics.com and through the Empower tele-medicine portal.
ABOUT EMPOWER
Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. It is expected that Empower's proprietary product line "Sollievo" will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based products in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.
ABOUT CANNVAS MEDTECH
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
PotterBanker
7年前
Cannvas Secures Partnership with Data-Driven Cannabis-Focused California Real Estate Firm
https://www.newswire.ca/news-releases/cannvas-secures-partnership-with-data-driven-cannabis-focused-california-real-estate-firm-872495035.html
Cannvas Data Platform To Provide Key Consumer, Retail Insights to Buyers Through Rebranded Company
TORONTO, April 17, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce Cannvas has entered into a definitive partnership with California-based real estate brokerage Good Karma, an innovative two-year-old agency specializing in the California commercial market, to provide detailed analysis and insights into the California market through its Cannvas Data platform while also undertaking a contemporary rebrand of the company.
"Through the analysis of high-level cannabis consumer data, Cannvas is well-positioned to support hopeful cannabis retailers with key demographic information on their target audiences, ensuring optimal location selection to drive awareness and profit," said Steve Loutskou, Chief Operating Officer, Cannvas Medtech Inc. "With this partnership between Good Karma and Cannvas, we are poised to help cannabis retailers target ideal locations for their business using the million-plus data points we have collected on potential and active cannabis consumers across North America."
According to a recent Allen Matkins/UCLA Anderson Forecast California Commercial Real Estate Survey, overall retail sales in the U.S. have increased at a 5.3 percent annual rate while retail markets struggle in California due to the onset of e-commerce that has grown at a 10.7 percent rate. However, industrial real estate is trending upward in the golden state, dominated by warehousing and distribution centres. Among its plans, Cannvas hopes to work with Good Karma to identify key industrial sites to act as strategically-placed distribution hubs for cannabis retailers across the state.
Cannvas expects this partnership to facilitate conversations with California cannabis producers and retailers looking to leverage a growing and diversifying customer base increasingly turning to cannabis to curb unhealthy habits or replace/complement traditional pain medication. Through the use of demographic and firmographic data, Cannvas can identify desirable consumer behaviour traits in specific regions across the state, helping to drive decisions on where to open up shop and reach new and potential customers.
With a population of nearly 40 million, California is considered to be among the largest recreational and medical cannabis markets in the world, alongside Canada. In the late 1990s, it was the first U.S. state to legalize medical cannabis and recreational cannabis sales became legal in January 2018. That year, the New York Times reports California retail stores sold US $2.5 billion of cannabis, compared to $1.5 billion or lower in Colorado, Washington and Oregon. According to BDS Analytics, the golden state is projected to account for nearly $25 billion of cannabis sales by 2026.
Good Karma was founded in Silicon Valley in 2016 by Len Sterling. A native of California and certified medical professional, Mr. Sterling has a reputation for prudent management from decades of experience in recruitment, sales and management.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
PotterBanker
7年前
Cannvas Partners with Leading U.S. Cannabis Kiosk Company, Seed Technology and Prepares Global Rollout
https://www.newswire.ca/news-releases/cannvas-partners-with-leading-u-s-cannabis-kiosk-company-seed-technology-and-prepares-global-rollout-886641785.html
Cannvas Acquires Exclusive Canadian Rights to Distribution of Co-Branded Kiosks
TORONTO, April 11, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce a definitive partnership with Seed Technology, a California, USA based interactive customer-focused cannabis education platform, granting Cannvas exclusive Canadian rights to distribute co-branded kiosks and related technology to medical clinics and dispensaries across Canada.
"Seed Technology has established itself as a premier purveyor of cannabis education to customers at dispensaries across the United States and we are excited to strategically partner with them and introduce an innovative co-branded concept to a Canadian market craving evidence-based information on cannabis and its potential health benefits," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "Partnering with Seed allows us to offer a wider range of cannabis education products and services through our Cannvas Kiosk initiative to better serve our partners and deliver accessible and unbiased cannabis learning resources to as many Canadians as possible."
Developed by Horizon Display - leading interactive experts providing and enhancing digital solutions for top brands such as Intel, Tesla, Nike, Disney and more for over 10 years - Seed was created to provide dispensaries with an advanced tool to improve customer experience, support staff and move product. Collaborating with a team of interactive education experts, scientists and cannabis industry specialists, Seed compiles accurate and timely information about cannabis and related products and transforms its research into one of the most advanced interactive education platforms in use at American dispensaries today.
The partnership allows for minimal capital requirements from Cannvas, as the Company gains access to Seed's existing facilities and services, including its comprehensive in-house system for the manufacturing, distribution and content creation of its kiosks. Plans are in the works to integrate Cannvas - and now Seed - learning kiosks with select health clinics and platforms from coast to coast whereby users engaging with the kiosk have an opportunity to follow up with a licensed medical practitioner, should they so choose, and these clinics or platforms will be among their options. Cannvas and Seed will also collaborate on integrating Cannvas.Me technology and content into Seed kiosks to further improve accessibility to free, unbiased and physician-backed education about the potential health benefits of medical and adult-use cannabis.
"This is a wonderful opportunity for all Canadians curious about cannabis consumption but unsure where to turn for reliable, accurate and timely education on its potential health benefits," said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. "Bringing the Seed kiosk brand to Canada increases our chances of reaching active and potential cannabis consumers where they shop, eat, work and live through on-site learning resources like the Cannvas.Me platform and equipping them with the information they need to make informed decisions on cannabis usage prior to speaking to their health care provider."
About Seed
Seed is developed by Horizon Display—leading interactive experts who have been providing digital solutions for top brands and enhancing retail environments and experiences for over 10 years. Seed was developed to provide dispensaries with an advanced tool to enhance the buying experience for their customers, support their staff, and sell more product. To create Seed, its team of researchers logged thousands of hours across several states speaking to scientists and industry specialists to compile the most up-to-date information about cannabis and related products. Its engineers, interactive education experts and designers then took that content to create one of the most advanced interactive education platforms available in dispensaries today. For more information, please visit getseed.io.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.
PotterBanker
7年前
Cannvas Secures Exclusive Cannabis Education and Analytics Partnership with US Cannabis Pharmaceutical
https://www.newswire.ca/news-releases/cannvas-secures-exclusive-cannabis-education-and-analytics-partnership-with-us-cannabis-pharmaceutical-800113473.html
USA Cannabis Market Projected To Reach Over $23B by 2022
TORONTO, April 10, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to establish a working partnership with US Cannabis Pharmaceutical Research and Development ("US Cannabis"), a resource for organizations seeking to normalize, legalize and develop medicinal cannabis. The deal positions Cannvas as an exclusive, leading provider of cannabis education and analytics to US Cannabis and its vast network of clients.
"As the global cannabis industry grows and the need for an arm's length third-party organization to provide unbiased education and information around all aspects of cannabis becomes more apparent, we're proud to partner with US Cannabis as their leading source of trusted cannabis-related learning," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. "This deal is structured to further our growth plans for 2019 while significantly expanding the reach of our educational and analytics platforms into the United States, a projected $23.4 billion market for recreational cannabis by 2022 and $8 billion for medicinal by 2024 according to BDS Analytics."
A key partnership for both organizations, Cannvas and US Cannabis will work together to deliver cannabis education to potential and active cannabis consumers through the Cannvas.Me digital learning resource. Cannvas will reinforce US Cannabis' goal of normalizing and developing medicinal and therapeutic cannabis through US Cannabis' vast partner network across the United States. Both companies believe educating the public about the investment, business and job opportunities around cannabis legalization will complement strengthened education on the plant's potential health benefits, and the Cannvas.Me platform is well-positioned to meet that challenge.
"Over the next 5 years, the global cannabis industry will grow faster than any other industry in the world," says Michael Patterson, CEO of US Cannabis. "Accurate data analytics and education from a trusted source are critical to the development of global standards of this new legal industry. Cannvas provides the best platform to use with our clients in the United States and abroad to facilitate consistent training, increased compliance with local, state, and federal laws, and create awareness of the consumer base locally and globally. We are proud to work with Cannvas to develop the gold standard for cannabis operations and compliance."
US Cannabis provides services to help an array of clients - from startups to seasoned investors, established operations to Native American tribes and government agencies. Cannvas will support these efforts through the licensing of educational software, the use of cannabis data and analytics to better understand key industry trends and drivers for the businesses with whom US Cannabis works closely, placement of Cannvas educational kiosks in existing US-based dispensaries and clinics, and other elements designed to elevate the level of learning Americans experience around cannabis. With more than a dozen states expected to pass new cannabis laws by 2025, according to New Frontier Data, the projected growth of the American cannabis market will provide many more opportunities for US Cannabis and Cannvas to work together as this partnership evolves.
About US Cannabis Pharmaceuticals
US Cannabis serves as a resource for organizations seeking to normalize, legalize and develop medicinal cannabis by engaging in commerce, marketing, regulatory reform and product/process development. Its mission is to move society forward through legalized cannabis. It believes the most powerful form of advocacy is commerce and the best way to promote cannabis is by working together to create a robust industry. US Cannabis seeks to achieve these objectives by helping clients ensure they meet licensing requirements, comply with regulations and effectively manage their operations to ensure success for all stakeholders. For more information, please visit www.uscprd.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company providing accessible and evidence-based education while harnessing the power of cannabis data and analytics to deliver deeper insights into consumer behaviour and paint a clearer picture of cannabis consumption across Canada.
PotterBanker
7年前
Cannvas Acquisitions Subsidiary Exploring Growth Opportunities Across United States
https://www.newswire.ca/news-releases/cannvas-acquisitions-subsidiary-exploring-growth-opportunities-across-united-states-899792451.html
Focus on Emerging Multi-Billion Dollar California Market
TORONTO, April 9, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce Cannvas Cannabis Acquisitions Corp. ("Cannvas Cannabis"), a wholly-owned subsidiary with a focus on investment and acquisition in the expanding global cannabis sector, has been actively exploring opportunities with data-driven organizations across the United States to expand its dataset of cannabis consumer trends through strategic partnership and merger and acquisition opportunities, with a significant focus on the US $2.5 billion California cannabis market.
"As America remains on the verge of exploding into the leading global cannabis marketplace, it is in the best interests of our organization and stakeholders to investigate all relevant growth opportunities for Cannvas and seek out strategic partners with whom we can grow all aspects of our company and contribute to the promotion of responsible and knowledge-based cannabis use," said Steve Loutskou, Chief Executive Officer, Cannvas Cannabis Acquisitions. "We are doing our due diligence in exploring a number of options to potentially expand the Cannvas brand into the United States, particularly California which represents nearly a third of the North American market and currently encompasses more than a million medical cannabis consumers."
With a population of nearly 40 million, approximately 10% of whom are legal medical cannabis users, California is considered to be among the largest recreational and medical cannabis markets in the world, alongside Canada. In the late 1990s, it was the first U.S. state to legalize medical cannabis and recreational cannabis sales became legal in January 2018. That year, California retail stores reportedly sold US $2.5 billion of cannabis, compared to $1.5 billion or lower in Colorado, Washington and Oregon. The golden state is projected to account for nearly $25 billion of cannabis sales by 2026.
Reports indicate more than 30% of all cannabis sales in California in 2018 were vapes, demonstrating the growing trend of more sophisticated and discerning audiences looking to learn more about alternative and healthier methods of ingestion. Cannvas hopes to leverage its educational and data analytics properties and work with retailers to offer consumers more robust education around the potential health benefits of cannabis, increase incremental sales through accessible product knowledge and better target potential and active users through in-depth analytics.
While Cannvas is actively seeking growth opportunities with American cannabis data organizations, the Company is also exploring options with U.S. entities on the distribution and fulfillment sides of the cannabis industry. The United States will likely one day represent the world's largest cannabis market, with 65 percent of its population already residing in states where cannabis is either medically and/or recreationally legal. According to BDS Analytics, the U.S. legal cannabis market is projected to reach US $20.9 billion by 2021.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
About Cannvas Cannabis Acquisitions
Cannvas Cannabis Acquisitions is a wholly-owned subsidiary of Cannvas MedTech with a focus on investment and acquisition in the expanding global cannabis sector. It seeks to complement the current product and services line offered by Cannvas through strategic investments and acquisitions, continuing development and discovery of emerging trends and patterns in the cannabis sector.
PotterBanker
7年前
Cannvas.Me experiences record 524% increase in user engagement and on track for 50 million article views and 4 million unique visitors
https://www.newswire.ca/news-releases/cannvas-me-experiences-record-524-increase-in-user-engagement-and-on-track-for-50-million-article-views-and-4-million-unique-visitors-843524489.html
Platform user base now spans over 80 countries and 1,100 cities around the world
TORONTO, March 26, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce unprecedented growth of its Cannvas.Me (www.cannvas.me) digital cannabis education platform as more global users from over 80 countries and 1,100 cities turn to Cannvas.Me for credible and evidence-based cannabis education. With user growth exceeding expectations and the platform's global reach expanding at a rapid pace, Cannvas.Me is poised to become the household name for cannabis education all while increasing its unique dataset to paint a clearer picture of cannabis consumption across Canada.
"We are thrilled with our consistent new user acquisition and the way in which we keep existing users interested and engaged with Cannvas.Me, adding targeted new sections based on user needs including Cannvas For Her, Physician's Corner, our upcoming Athlete's Corner and much much more," said Shawn Moniz, Chief Executive Officer. "With so many visitors to Cannvas.Me in such a short period of time, it's clear not only Canadians, but the global audience of the 80 countries using our platform are starved for more in-depth evidence-based education on cannabis and understand that Cannvas has evolved into a trusted resource for physician-backed information on all aspects of the plant."
Since the launch of Cannvas.Me in October, the educational platform has experienced a consistent month-to-month user growth of 30%, with a meteoric rise of 524% in March. The site is now on track to have over 4 million unique users accessing its free and unbiased cannabis education in 2019, with over 50 million views of Cannvas articles and courses before year's end.
This puts Cannvas on track to have over 90% of countries around the world engaging with its content before the end of 2019.
The average session duration for Cannvas.Me users has also increased month-to-month since the site's launch, up 10% each month in the past six months. With users spending an average of nearly 10 minutes on the site per visit."Through a network of strategic partnerships focused on content and data sharing, coupled with a groundswell of global users looking to learn more about cannabis, Cannvas continues to outpace expectations as it surpasses growth projections," said Steve Loutskou, Chief Operating Officer, Global Markets. "We are thrilled with these results and expect our media and advertising partners to feel the same as their products and services are reaching more relevant audiences as our revenue streams continue to grow alongside our user base."
The Company announced that it has issued a total of 38,000 common shares at a deemed price of $0.265 per common share to a service provider pursuant to a consulting agreement entered into with the service provider.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
PotterBanker
7年前
Cannvas Exhibits Cannabis Data AI Technologies at Cantech Conference
https://www.newswire.ca/news-releases/cannvas-exhibits-cannabis-data-ai-technologies-at-cantech-conference-824110305.html
Speaking Engagements to Demonstrate Importance of Big Data and Analytics
TORONTO, Jan. 29, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis educator and data company, is pleased to announce it will have a substantial presence at the 2019 Cantech Investment Conference, taking place January 29-30 at the Metro Toronto Convention Centre in the heart of the city's downtown core.
"We are thrilled to be exhibiting our Cannabis Data AI technology and being part of the Cannabis and Big Data Panel. We have a significant presence at this year's Cantech Investment Conference, and with it the opportunity to signal to investors how our Cannabis Data AI is at the cusp of driving substantial growth in the industry as a major catalyst for licensed producers and dispensaries here in Canada" said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc.
Cannvas MedTech will be at booth 622 at this year's Cantech conference, with speaking engagements scheduled on each day of the conference. On Tuesday, January 29, CEO Shawn Moniz will participate in a discussion panel on the subject of Cannabis and Big Data, moderated by a member of Toronto law firm Fogler Rubinoff LLP. On Wednesday, January 30, Shawn will take to the Paradigm Stage for a featured speaking appearance expected to stress the importance of cannabis analytics in a nascent industry, positioning Cannvas as a leading source of comprehensive and unbiased information on the behaviours of active and potential cannabis consumers across Canada.
While at the conference, the senior management team at Cannvas expects to meet and connect with hundreds of leading Canadian technology companies, schedule private meetings with business leaders and influencers, and learn more about potential partnership opportunities with like-minded organizations.
The Cantech Investment Conference is put on by Cambridge House International, producing North America's largest resource conferences and Canada's largest technology investment conference. For 25 years, Cambridge House has produced flagship must-attend events and provided industries with platforms for networking, education and investment discovery. Cantech is a hallmark event attracting investors and media from across North America to meet with Canadian innovation entrepreneurs.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.
Hot Features
プレミアム
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Dewayne18
2年前
Renee
2年前
greenwillow
7年前
メールアドレスで登録
